1. Home
  2. NEN vs CGEN Comparison

NEN vs CGEN Comparison

Compare NEN & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

NEN

New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

N/A

Current Price

$44.00

Market Cap

197.0M

Sector

Real Estate

ML Signal

N/A

Logo Compugen Ltd.

CGEN

Compugen Ltd.

N/A

Current Price

$2.09

Market Cap

201.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEN
CGEN
Founded
1977
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.0M
201.8M
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
NEN
CGEN
Price
$44.00
$2.09
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $4.80
AVG Volume (30 Days)
1.2K
★ 229.9K
Earning Date
11-13-2026
11-09-2026
Dividend Yield
★ 3.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
★ $89,196,544.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$55.33
P/E Ratio
$19.68
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.24
$1.43
52 Week High
$71.07
$3.24

Technical Indicators

Market Signals
Indicator
NEN
CGEN
Relative Strength Index (RSI) 32.93 49.52
Support Level N/A $1.98
Resistance Level $66.30 $2.33
Average True Range (ATR) 0.63 0.09
MACD -0.06 0.03
Stochastic Oscillator 0.00 73.68

Price Performance

Historical Comparison
NEN
CGEN

About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating, and selling real estate. The Partnership owns and operates various residential apartments, condominium units, and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent, and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: